Deep Science Ventures

Deep Science Ventures (DSV) is a pioneering venture studio and fund dedicated to systematically developing and investing in science-driven companies. The firm employs a unique "solution-pull" methodology, which involves identifying critical global challenges and working backward to create optimal scientific and technological solutions, rather than waiting for new discoveries to emerge. This approach allows DSV to bridge the gap between cutting-edge scientific research and entrepreneurial execution, fostering the creation of high-impact ventures across various sectors.

Founded in 2016 by Dominic Falcao and Mark Hammond, Deep Science Ventures emerged from a desire to radically rethink how science-based companies are built. Falcao previously led Imperial College London's science startup program, while Hammond, with a PhD in Neuropharmacology and AI, built Imperial College's deep-tech startup accelerator. Their combined experience in nurturing early-stage science startups and facilitating academic spin-outs laid the groundwork for DSV's systematic venture creation model. The firm started without initial funding, iterating on its model to secure backing from angel investors and grow significantly.

DSV focuses its investments and venture creation efforts across key sectors including Pharmaceuticals (Pharma), Climate, Agriculture, Computation, and Education. Notable portfolio companies include Antiverse, which specializes in de novo antibody design; Rhizocore, focused on restoring underground forest networks; Mission Zero Technologies, working on direct air capture; and HyperCIM, developing lossless computing hardware. Other ventures include Xonai, CureAge, Parallel Carbon, Dunia, Neobe Therapeutics, Bastion Therapeutics, Modjoule, Ironic Metals, and HotGreen.

The team at Deep Science Ventures comprises individuals with deep technical expertise and entrepreneurial backgrounds, many holding PhDs and possessing C-suite founder experience. Key team members include co-founders Dominic Falcao and Mark Hammond, along with individuals like Javier Noris (Global Funding Lead) and Santa Astratova (Head of Talent). [cite: 2 from previous step] DSV also runs a Venture Science Doctorate program, training founder-type scientists to translate research into scalable ventures, thereby addressing the talent bottleneck in science commercialization.